ESMO 2024 Insights: ARROS-1 Study - Zidesamtinib in Advanced ROS1 Fusion-Positive NSCLC and Other Solid Tumors
ESMO 2024 Insights: ARROS-1 Study - Zidesamtinib in Advanced …
Oct 2, 2024
vumedi.com
Emerging ALK/ROS1 TKIs for NSCLC | OncLive
Emerging ALK/ROS1 TKIs for NSCLC | OncLive
Jan 31, 2017
onclive.com
Dr. Drilon on Entrectinib in Patients With ROS1-Positive NSCLC
Dr. Drilon on Entrectinib in Patients With ROS1-Positive NSCLC
Oct 17, 2017
onclive.com
Considerations for Sequencing in ALK NSCLC | OncLive
Considerations for Sequencing in ALK NSCLC | OncLive
Jun 16, 2017
onclive.com
Repotrectinib in Patients With ROS1 NSCLC
Repotrectinib in Patients With ROS1 NSCLC
390 viewsFeb 28, 2024
vumedi.com
Development of ALK-Targeted Therapy for NSCLC
Development of ALK-Targeted Therapy for NSCLC
Jun 16, 2017
onclive.com
Treatment Sequencing Decisions in ROS1 NSCLC
Treatment Sequencing Decisions in ROS1 NSCLC
9 months ago
onclive.com
Current Management of ROS1 rearranged NSCLC | OncLive
Aug 17, 2020
onclive.com
Upfront Therapy for ALK/ROS1-Rearranged NSCLC | OncLive
3 weeks ago
onclive.com
Updates in the Treatment of ALK+ and ROS1+ NSCLC | OncLive
1 week ago
onclive.com
Dr. Doebele on Significant Findings of Entrectinib in Patients With RO…
Oct 19, 2017
onclive.com
4:02
Findings for Zidesamtinib in Advanced ROS1 NSCLC and Othe…
Oct 28, 2024
onclive.com
2:56
Dr Mok on the Efficacy of Taletrectinib in ROS1+ NSCLC | O…
1 week ago
onclive.com
2:09
Dr Liu on the TRUST-II Trial of Taletrectinib in ROS1 NSCLC | On…
Dec 6, 2024
onclive.com
Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesam…
5 months ago
fox4kc.com
2:23
Dr Nagasaka on the Importance of Taletrectinib for the ROS1 NSCLC …
8 months ago
onclive.com
2:32
Dr Dietrich on the Efficacy and Safety of Taletrectinib in ROS1 NS…
7 months ago
onclive.com
Dr Liu on Updated Efficacy and Safety Data With Taletrectinib in R…
5 months ago
onclive.com
0:59
Dr. Tejas Patil Explains ROS1 Positive Lung Cancer. Listen to th…
158 views1 week ago
FacebookLCFA: Lung Cancer Foundation of America
Phase I/II ARROS-1 Study of Zidesamtinib (NVL-520) in ROS1 F…
Sep 30, 2024
onclive.com
Nuvalent, Inc.: Nuvalent Announces Positive Pivotal Data from ARRO…
8 months ago
finanznachrichten.de
10:26
What is ROS1 Lung Cancer? The Basics Explained With Dr. Rodrigu…
4 views1 month ago
YouTubeYoung Lung Cancer Initiative
Trending in Oncology: Orphan Drug Wins, Breast Cancer Approvals an…
5 months ago
YouTubeLucidQuest
1:05:06
$BMY Bristol Myers Squibb Q4 2025 Earnings Conference Call
26 views3 weeks ago
YouTubeEARNMOAR
9:02
Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer - Lung Ca…
8 views2 months ago
YouTubeGlobal Resource for Advancing Cancer Education
0:49
GO2 for Lung Cancer on Instagram: "🚨 FDA approval alert! The @fda ha…
1.2K views8 months ago
Instagramgo2forlungcancer
Future Directions for ROS1 rearranged mNSCLC
Aug 17, 2020
onclive.com
Dr Bazhenova on Updated Data From the TRUST-I Trial of Taletrec…
168 viewsAug 8, 2024
YouTubeOncLive
2:12
Cancer immunotherapy | The PD-L1 pathway
214.7K viewsMay 26, 2016
YouTubeRoche
8:25
EGFR & ALK/ROS1 Testing in Squamous NSCLC
1.6K viewsFeb 21, 2017
YouTubeOncLive
See more videos
Static thumbnail place holder